Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CNB Financial | CCNE | Nov 22, 2024 | 28.13 | +1.99 |
CNB Financial Pref | CCNEP | Nov 22, 2024 | 25.03 | +0.42 |
CNFinance ADR | CNF | Nov 22, 2024 | 0.96 | +1.16 |
CNH Industrial N.V. | CNH | Nov 22, 2024 | 12.15 | +1.93 |
CNO Financial Group | CNO | Nov 22, 2024 | 39.91 | +1.35 |
CNS Pharmaceuticals | CNSP | Nov 22, 2024 | 0.12 | -4.31 |
CNX Resources | CNX | Nov 22, 2024 | 41.09 | +1.11 |
Co-Diagnostics | CODX | Nov 22, 2024 | 1.01 | -4.72 |
Coastal Financial | CCB | Nov 22, 2024 | 76.69 | +1.81 |
Coca-Cola | KO | Nov 22, 2024 | 63.92 | +0.25 |
Coca-Cola Consolidated | COKE | Nov 22, 2024 | 1 259.92 | +1.10 |
Coca-Cola Europacific Partners | CCEP | Nov 22, 2024 | 78.21 | +0.13 |
Coca-Cola FEMSA ADR | KOF | Nov 22, 2024 | 79.06 | +1.46 |
Cocrystal Pharma | COCP | Nov 22, 2024 | 2.20 | +2.33 |
Coda Octopus | CODA | Nov 22, 2024 | 9.32 | -1.58 |
Codere Online Luxembourg | CDRO | Nov 22, 2024 | 7.60 | +4.11 |
Codexis | CDXS | Nov 22, 2024 | 4.61 | +6.47 |
Coeptis Therapeutics | COEP | Nov 22, 2024 | 0.19 | +2.48 |
Coeur Mining | CDE | Nov 22, 2024 | 6.57 | -0.91 |
Coffee Holding Company | JVA | Nov 22, 2024 | 3.49 | -3.72 |
Cogent Biosciences | COGT | Nov 22, 2024 | 9.13 | +1.67 |
Cogent Communications | CCOI | Nov 22, 2024 | 83.16 | -0.76 |
Cognex | CGNX | Nov 22, 2024 | 40.67 | +3.75 |
Cognition Therapeutics | CGTX | Nov 22, 2024 | 0.43 | -2.75 |
Cognizant Technology Solutions A | CTSH | Nov 22, 2024 | 79.54 | +0.86 |
Cognyte Software | CGNT | Nov 22, 2024 | 7.82 | -3.81 |
Cohen & Company | COHN | Nov 22, 2024 | 10.20 | +5.04 |
Cohen & Steers | CNS | Nov 22, 2024 | 103.42 | +1.40 |
Cohen & Steers Closedend Opportunity Fund | FOF | Nov 22, 2024 | 13.09 | +0.61 |
Cohen & Steers Duration Pref and Income Fund | LDP | Nov 22, 2024 | 20.96 | -0.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.